CHAIM POPER
Allopathic & Osteopathic Physicians|Internal Medicine MONROE, NY NPI 1346745908
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$792.20
- Category: General Payments
- Program years: PY2022–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $195.50 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $195.50 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $73.77 | 3 |
| PFIZER INC. | $60.75 | 3 |
| Lilly USA, LLC | $25.59 | 1 |
| Meridian Bioscience Inc. | $18.80 | 1 |
| Novo Nordisk AS | $16.59 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097791271 | Novo Nordisk Inc | $16.59 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104622200 | AstraZeneca Pharmaceuticals LP | $23.97 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105689804 | AstraZeneca Pharmaceuticals LP | $33.88 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105811643 | AstraZeneca Pharmaceuticals LP | $15.92 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131285510 | PFIZER INC. | $18.38 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131396723 | PFIZER INC. | $20.38 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132005652 | PFIZER INC. | $21.99 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136094469 | Lilly USA, LLC | $25.59 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137917214 | Meridian Bioscience Inc. | $18.80 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.